A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

Clinical trial NCT05997290 · COMPLETED

Trial details

NCT number: NCT05997290
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection COVID-19

Start date: 2023-08-10
Primary completion: 2025-03-13
Enrollment: 1051

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.